Omega-3s and the Aging Brain: What the Research Actually Shows After 55

In the Framingham Heart Study, adults whose red blood cell omega-3 levels fell in the lowest fifth had measurably smaller hippocampi — the brain's memory center — than peers in the top fifth. The gap was roughly equivalent to two extra years of brain aging on MRI. Unlike most things that age the brain, this one you can actually change in three to four months.

If you are over 55, that single finding is worth pausing on. The omega-3 status in your bloodstream is one of the few brain-aging variables that responds quickly to a change in diet or supplementation. This article walks through what the science actually says, what it does not say, and what a reasonable, evidence-based plan looks like.

Why omega-3s matter more after 55

Omega-3 fatty acids are a family of polyunsaturated fats. The three you hear most about are ALA (from plants like flaxseed and walnuts), and EPA and DHA, which come almost entirely from marine sources — fatty fish like salmon, sardines, mackerel, and herring, or from algae. DHA is the structural fat: roughly 40 percent of the polyunsaturated fat in your brain's gray matter is DHA, building the membranes of your neurons. EPA is more of an anti-inflammatory signaling molecule. Both matter.

Three things change after 55. Most American adults already eat less than half the EPA plus DHA the American Heart Association recommends for cardiovascular health. The body's ability to convert plant-based ALA into the DHA the brain uses becomes less efficient with age — and it was never very efficient to begin with, often under five percent. And the brain itself is more vulnerable in this decade, with white matter lesions accumulating and hippocampal volume shrinking roughly half a percent per year after 60 on average.

Study One: The Framingham midlife MRI study

In 2022, researchers led by Claudia Satizabal at UT Health San Antonio published a landmark analysis in Neurology, looking at 2,183 dementia- and stroke-free participants from the Framingham Heart Study Offspring cohort. They measured the omega-3 index — the percentage of EPA plus DHA in red blood cell membranes — and correlated it with brain MRI markers and cognitive testing.

A higher omega-3 index was independently associated with larger hippocampal volumes and better performance on tests of abstract reasoning. The effect was visible even in midlife, suggesting the benefit accrues over decades. Citation: Satizabal CL et al., Neurology, 2022, 99(23):e2572–e2582. DOI: 10.1212/WNL.0000000000201296.

Study Two: WHIMS-MRI and the hippocampus

A few years earlier, James Pottala and colleagues published results from the Women's Health Initiative Memory Study MRI sub-study in Neurology. They followed 1,111 postmenopausal women, measured red blood cell EPA and DHA at baseline, and waited roughly eight years before performing brain MRIs. The average age at scan was 78.

Women in the highest quartile of EPA plus DHA had hippocampal volumes about 2.7 percent larger than women in the lowest quartile, even after adjusting for cardiovascular risk factors, education, and APOE genotype. Two-point-seven percent does not sound dramatic until you remember this is the exact region first hit by Alzheimer's pathology. Citation: Pottala JV et al., Neurology, 2014, 82(5):435–442. PMID: 24453077.

Study Three: The JAMA Network Open APOE4 trial (2024)

In 2024, a randomized, double-blind, placebo-controlled trial published in JAMA Network Open tested whether omega-3 supplementation could slow white matter lesion progression and protect neuronal integrity in older adults at elevated dementia risk. The trial enrolled 102 participants and followed them for three years.

Across all participants, the effect did not reach statistical significance. But when researchers analyzed APOE ε4 carriers separately — the gene variant that raises Alzheimer's risk roughly threefold in heterozygotes — the omega-3 group showed significantly less breakdown of neuronal integrity on diffusion tensor imaging compared to placebo. The implication: omega-3 may not be a universal brain protector, but for genetically high-risk individuals, the signal is real. Trial available at PMC11294966.

Study Four: The PreventE4 trial

Hussein Yassine's group at the University of Southern California ran a complementary trial called PreventE4 (ClinicalTrials.gov NCT03613844). They gave 2 grams per day of DHA, or placebo, to adults aged 55 to 80 who were cognitively normal but had low dietary DHA intake and at least one dementia risk factor. Critically, they measured DHA directly in cerebrospinal fluid — the fluid bathing the brain itself.

The key finding, published in The Journal of Prevention of Alzheimer's Disease: APOE ε4 carriers showed lower delivery of DHA from blood into brain tissue than non-carriers. In plain language, the people who likely need DHA the most have the hardest time getting it into their brains, suggesting they may need higher dietary or supplemental amounts. Citation: Yassine HN et al., J Prev Alzheimers Dis, 2023. DOI: 10.14283/jpad.2023.77.

Study Five: Mood and depressive symptoms

The brain is not just memory — mood matters too, particularly after 55 when life transitions and bereavement can elevate depression risk. A 2024 systematic review and meta-analysis by Chang and colleagues, published in Healthcare, pooled randomized trials of omega-3 supplementation in older adults and patients with dementia. DHA-predominant supplementation showed a statistically significant reduction in depressive symptoms in the elderly subgroup. Effect sizes were modest — omega-3 is not a substitute for treatment of clinical depression — but the data support DHA as a reasonable adjunct for low-grade mood symptoms. Citation: Chang JP et al., Healthcare, 2024, 12(5):536. DOI: 10.3390/healthcare12050536.

Five practical, evidence-based steps

1. Eat fatty fish at least twice a week. Salmon, sardines, mackerel, herring, anchovies, and trout are the highest-density sources. A 3.5-ounce serving of wild salmon provides roughly 1.5 to 2 grams of combined EPA plus DHA — the amount used in most of the trials above.

2. Know your number. Ask your physician about an omega-3 index blood test. The target most researchers cite is an omega-3 index of 8 percent or higher. The lowest-quartile groups in Framingham sat near 4 percent.

3. If you supplement, pick wisely. Look for a product that specifies EPA and DHA in milligrams — not just "fish oil." A reasonable starting point in the literature is 1 to 2 grams per day of combined EPA plus DHA. Third-party certifications like USP, IFOS, or NSF meaningfully reduce the risk of oxidized or contaminated product. If you cannot tolerate fish oil, algae-derived DHA is a vegetarian alternative with comparable bioavailability.

4. Discuss APOE if there is dementia in your family. If a parent or sibling has been diagnosed with Alzheimer's, knowing your APOE status changes the calculus. APOE ε4 carriers may benefit disproportionately from DHA, and the standard "1 to 2 grams" dose may need to be on the higher end.

5. Pair it with the rest of the brain-health bundle. Omega-3 is not a standalone fix. The biggest cognitive benefits show up when omega-3 status is combined with regular aerobic exercise, blood pressure control, adequate sleep, and a MIND or Mediterranean-style dietary pattern.

Medical disclaimer. This content is for educational purposes only and is not a substitute for professional medical advice. Always consult your physician before starting any supplement, especially if you take anticoagulant or antiplatelet medications (warfarin, apixaban, clopidogrel, aspirin), have a bleeding disorder, are scheduled for surgery, or have a seafood allergy.